25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer
- 28 May 2002
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 81 (2), 135-140
- https://doi.org/10.1016/s0960-0760(02)00053-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Enhancing 1α-Hydroxylase Activity with the 25-Hydroxyvitamin D-1α-Hydroxylase Gene in Cultured Human Keratinocytes and Mouse SkinJournal of Investigative Dermatology, 2001
- Gene therapy for prostate cancerUrology, 2001
- Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)Cancer Causes & Control, 2000
- Editorial/Mini-Review: Vitamin D and Prostate CancerEndocrinology, 2000
- The Current Status of Gene Therapy for Prostate Cancer.Cancer Control, 1998
- Current Understanding of the Molecular Actions of Vitamin DPhysiological Reviews, 1998
- Antiproliferative Effect of 1 ,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cell Line LNCaP Involves Reduction of Cyclin-Dependent Kinase 2 Activity and Persistent G1 AccumulationEndocrinology, 1998
- Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3Endocrinology, 1995
- The Antiproliferative and Differentiative Activities of 1,25-Dihydroxyvitamin D3 Are Potentiated by Epidermal Growth Factor and Attenuated by Insulin in Cultured Human KeratinocytesJournal of Investigative Dermatology, 1995
- Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3Biochemistry, 1986